Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma

Moolten FL . Drug sensitivity (“suicide”) genes for selective cancer chemotherapy Cancer Gene Ther 1994 1: 279–287

Short MP, Choi BC, Lee JK, et al . Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line J Neurosci Res 1990 27: 427–439

Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection Mol Cell Biol 1990 10: 4239–4242

Lyons RM, Forry-Schaudies S, Otto E, et al . An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo Cancer Gene Ther 1995 2: 273–280

Boviatsis EJ, Park JS, Sena-Esteves M, et al . Long term survival of rats harbouring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene Cancer Res 1994 15: 5745–5751

Oldfield EH, Ram Z, Culver KW, et al . Gene therapy for the treatment of brain tumors using intra-tumoral transduction with thymidine kinase gene and intravenous ganciclovir Hum Gene Ther 1993 4: 39–69

Ram Z, Culver KW, Walbridge S, et al . In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats Cancer Res 1993 53: 83–88

Moolten FL, Wells JM . Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J Natl Cancer Inst 1990 82: 297–300

Ram Z, Culver KW, Oshiro EM, et al . Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nat Med 1997 3: 1354–1361

Culver KW, Van Gilder J, Link CJ . Clinical protocol: Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system Hum Gene Ther 1994 5: 343–379

Shand N, Weber F, Mariani L, et al . A phase 1–2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir Hum Gene Ther 1999 10: 2325–2335

Namba H, Tagawa M, Iwadate Y, et al . Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells Hum Gene Ther 1998 9: 5–11

Freeman SM, Ramesh R, Shastri M, et al . The role of cytokines in mediating the bystander effect using HSV-Tk xenogenic cells Cancer Lett 1995 92: 167–174

Whartenby KA, Ramesh R, Marrogi AJ, et al . The biology of cancer gene therapy Lab Invest 1995 72: 131–145

Namba H, Iwadate Y, Tagawa M, et al . Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging Hum Gene Ther 1996 7: 1847–1852

Samejima Y, Meruelo D . “Bystander killing” induces apoptosis and is inhibited by forskolin Gene Ther 1995 2: 50–58

Freeman SM, Abboud CN, Whartenby KA, et al . The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274–5283

Culver KW, Ram Z, Walbridge S, et al . In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors Science 1992 256: 1550–1552

Moriuchi S, Krisky DM, Marconi PC, et al . HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma Gene Ther 2000 7: 1483–1490

Ramesh R, Marrogi AJ, Freeman SM . Tumor killing using the HSV-tk suicide gene Gene Ther Mol Biol 1998 1: 253–263

Dilber MS, Abedi MR, Christensson B, et al . Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo Cancer Res 1997 57: 1523–1528

Elshami AA, Saavedra A, Zhang H, et al . Gap junctions play a role in the bystander effect of the herpes simplex virus thymidine kinase/ganciclovir system in vitro Gene Ther 1996 3: 85–92

Ram Z, Walbridge S, Shawker T, et al . The effect on tumoral vasculature and growth of thymidine kinase-transduced, ganciclovir-treated 9L gliomas in rats J Neurosurg 1994 81: 256–260

Vile RG, Nelson JA, Castleden S, et al . Systemic gene therapy of murine melanoma using tissue specific expression of the HSV-Tk gene involves an immune component Cancer Res 1994 54: 6228–6234

Colombo BM, Benedetti S, Ottolenghi S, et al . The “bystander effect”: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice Hum Gene Ther 1995 6: 763–772

Long Z, Lu P, Grooms T, et al . Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy Hum Gene Ther 1999 10: 733–740

Deliganis AV, Baxter AB, Berger MS, et al . Serial MR in gene therapy for recurrent glioblastoma: initial experience and work in progress Am J Neuroradiol 1997 18: 1401–1406

Smith MM, Thompson JE, Castillo M, et al . MR of recurrent high-grade astrocytomas after intralesional immunotherapy Am J Neuroradiol 1996 17: 1065–1071

Henegar MM, Moran CJ, Silbergeld DL . Early postoperative magnetic resonance imaging following nonneoplastic cortical resection J Neurosurg 1996 84: 174–179

Albert FK, Forsting M, Sartor K, et al . Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis Neurosurgery 1994 34: 45–61

Ramesh R, Marrogi AJ, Munshi A, et al . In-vivo analysis of the “bystander effect”: a cytokine cascade Exp Hematol 1996 24: 829–838